EDB-FN expression and the infiltration of CD4+ and CD8+ T lymphocytes in the tumors were determined by immunohistochemistry (IHC) and immunofluorescence (IF) staining, respectively, and correlated with MRMI observations, tumor response, and therapeutic outcomes. The gene discussed is CD8A; the disease is neoplasm.